Evidence map›Paper›PMID 35991839›Full record

ArticlePathology oncology research : POR2022

Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer.

Jie Wang, Rehana Akter, Md Fahim Shahriar, Md Nazim Uddin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Cancers · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Unraveling the metastatic niche in breast cancer bone metastasis through single-cell RNA sequencing.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Jie WangDepartment of Pharmacy, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Rehana AkterBioinformatics Research Lab, Center for Research Innovation and Development (CRID), Dhaka, Bangladesh.
Md Fahim ShahriarSchool of Pharmacy, China Pharmaceutical University, Nanjing, China.
Md Nazim UddinInstitute of Food Science and Technology, Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, Bangladesh.
Bangladesh Council of Scientific and Industrial Research · BDChina Pharmaceutical University · CNFirst Affiliated Hospital of Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaCancer-Associated FibroblastsColonic NeoplasmsBiomarkers, TumorExtracellular Matrix ProteinsGene Expression Regulation, NeoplasticHumansImmunosuppression TherapyTranscriptomeTumor MicroenvironmentBiomarkers, TumorCTHRC1 protein, humanExtracellular Matrix Proteinscancer-associated fibroblastscolon cancerimmunosuppressive rolesmetastatic scoressurvival time

Identifiers

PMID35991839
PMCPMC9385976
OpenAlexW4289730886

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.